AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Tommy T Ly

Examiner Tommy T Ly appears to be about average relative to their peer examiners. Their lifetime grant ratio is 57.1%, they average 2.10 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Easy
Difficulty vs Group Very Easy
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 2.10
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-6404
Predicted Supervisor
Anhtuan Nguyen
Supervisor Phone
(571) 272-4963
Tech Center
3700 - Mechanical Engineering, Manufacturing and Products
Group
3790 - Medical Instruments, Diagnostic Equipment, and Treatment Devices

Metrics

Applications Evaluated
161
Granted Applications
92
Non-Granted Applications
69
Avg OA / Grant
2.10
Last OA Observed
July 2026 (1 months ago)
Art Units Seen
3793 , 3797
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 57.1% 2.10
Art Unit 18 41.6% 2.21
Group 335 39.2% 2.25
Tech Center 2,662 48.9% 2.01
USPTO 16,347 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 18 10 55.6%
2023 43 36 83.7%
2024 39 35 89.7%
2025 24 11 45.8%
2026 37 0 0.0%

92 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 156 0.0% 2.6% 83.3% 2.6%
2 87 1.1% 1.1% 93.1% 1.1%
3 51 0.0% 3.9% 96.1% 0.0%
4 30 0.0% 3.3% 93.3% 3.3%
5 6 0.0% 0.0% 83.3% 0.0%
6 2 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2021
0.0%
2022
1.2%
2023
0.0%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.